- Home
- »
- Beauty & Personal Care
- »
-
Pet Calming Products Market Size, Share Report, 2026-2033GVR Report cover
Pet Calming Products Market (2026 - 2033)
Size, Share & Trends Analysis Report By Pet (Dog, Cat), By Product (Food & Supplements, Snacks & Treats, Gel & Ointment, Spray & Mist), By Type, By Ingredient, By Distribution Channel, By Region, And Segment Forecasts
Market Size, 2025
$18.1BMarket Estimate, 2026
$19.1BMarket Forecast, 2033
$29.9BCAGR, 2026–2033
6.6%Pet Calming Products Market Summary
The global pet calming products market size was valued at USD 18.1 billion in 2025 and is projected to grow from USD 19.1 billion in 2026 to USD 29.9 billion by 2033, at a CAGR of 6.6% from 2026 to 2033. The market in North America dominated with a revenue share of 39.1% in 2025. In recent years, there has been a significant surge in pet adoption, particularly in the U.S.
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,
Download Free Sample Report Key Market Trends & Insights
- By pet type: Dogs segment dominated the market, with a revenue share of 52.3% in 2025.
- By product: Snacks and treats segment held the largest market share of 37.9% in 2025.
- By type: Over-the-counter (OTC) segment accounted for the largest revenue share of 62.9% in 2025.
- By distribution channel: Offline segment held the largest market share of 65.2% in 2025.
- By ingredient: Melatonin segment held the largest revenue share of 27.5% in 2025.
Regional Highlights
- Largest regional market: North America (39.1% revenue share, 2025)
- By country: U.S. held the largest market share in 2025.
Market Size & Forecast
- Market size in 2025: USD 18.1 Billion
- Estimated market size in 2026: USD 19.1 Billion
- Projected market size by 2033: USD 29.9 Billion
- CAGR (2026-2033): 6.6%
Three ways to get this report
Buy it, customize it, or ask a question.Ask an Analyst
Analyst response in 1 business day
- AccessReport author, directly
- Reply timeWithin 1 working day
- No sales callDirect answer only
- FormatEmail reply
- CostFree, no cost
Get the Full Report
What the study covers
- FormatsPDF · Excel · Dashboard
- Timeline2026–2033 annual, 2025 base
- Coverage20+ countries, 5 regions
- Companies10+ key players profiled
Customize the Report
20% free customization
- IncludeCountries, segments, points
- TailorTo your product definition
- ExtendDeeper competitor detail
- OrA fully bespoke study
- Turnaround5–10 working days
The preference for dogs and cats as pets remains steadfast in different regions in the U.S. According to the American Society for the Prevention of Cruelty to Animals, one in five Americans acquired a pet during the pandemic. In 2020, 90.5 million families in the U.S. adopted pets, spending a combined total of USD 103.6 billion on pet care. Pet calming is an essential aspect of pet care, as it directly addresses the emotional and behavioral well-being of pets. Just as physical health and hygiene are integral to overall pet care, mental health plays a crucial role in ensuring that pets live happy, healthy lives. Many pets experience stress and anxiety from various triggers, such as separation from their owners, unfamiliar environments, loud noises, or changes in routine.
To learn more about this report, Download Free Sample Report The global pet calming products industry has seen significant growth driven by increasing awareness of pet mental health and a surge in pet ownership worldwide. Pet owners are increasingly seeking solutions to manage their pets' anxiety, stress, and behavioral issues, which has led to the popularity of calming products. As pet anxiety disorders, including separation anxiety, noise phobia, and fear-related behaviors, become more recognized, the demand for calming solutions such as pheromone-based sprays, collars, diffusers, and other calming aids has expanded.
For instance, brands like Adaptil and Feliway, which specialize in calming products, have seen increased sales globally due to the growing demand for effective, natural solutions to pet anxiety. In addition to pheromone-based products, supplements, calming chews, and anxiety wraps have gained traction in the market.
There is a growing awareness among pet owners about the importance of pet health and well-being. This increased awareness results in an increased focus on calming routines as an essential aspect of pet care. Pet owners look for calming products that not only help with the anxiety but also contribute to the overall well-being of their pets.
Pet calming products are one of the niche categories in the pet care market. The global rise in pet adoption and the high demand for pet products, as well as grooming & therapy services, are some of the major factors anticipated to drive the market through 2030. Pheromone-based pet calming products encompass a diverse range of products, including sprays, diffusers, collars, gels & ointment among others designed to address various pet calming needs.
Consumer spending on pet-related requirements has significantly increased due to pet humanization. Pets are increasingly viewed as integral members of the family. This shift in perception prompts pet owners to invest in calming products that prioritize their pets' comfort, health, and aesthetics, echoing the care they provide for themselves and their human family members.
Market Dynamics
The global pet calming products market is being driven by rising pet humanization, increasing awareness of pet anxiety and behavioral health, and growing willingness among owners to spend on preventive pet wellness solutions. Demand is expanding beyond veterinarian-prescribed treatments toward OTC calming supplements, treats, pheromone products, and natural formulations designed to manage stress associated with separation anxiety, travel, noise sensitivity, grooming, and environmental changes. However, market growth remains influenced by limited clinical standardization across products and varying consumer perceptions regarding product effectiveness.
A key driver for the pet calming products market is the growing recognition of anxiety-related conditions among companion animals. Increased pet ownership, stronger human-animal bonds, and greater awareness of behavioral health issues are encouraging pet owners to seek products that help manage stress caused by travel, thunderstorms, fireworks, veterinary visits, separation, and changes in routine. This trend is supporting demand across supplements, treats, pheromone products, and other calming solutions.
Market growth is constrained by the absence of universally accepted efficacy standards for many OTC calming products. Product performance often varies by pet, anxiety trigger, and formulation, leading some consumers to remain skeptical about effectiveness. This can slow repeat purchases and create challenges for manufacturers seeking to differentiate products in an increasingly crowded marketplace.
A significant opportunity exists in the increasing demand for natural and functional calming solutions formulated with ingredients such as L-theanine, melatonin, chamomile, valerian root, probiotics, and other wellness-focused compounds. As pet owners increasingly prioritize preventive care and holistic health management, manufacturers are expanding portfolios with science-backed, clean-label, and veterinarian-recommended products. This trend is expected to support premiumization and drive value growth across the pet calming products market.
Analyst Perspective
The pet calming products market is primarily pet wellness and behavioral health-driven, with demand closely linked to rising pet ownership, increasing awareness of anxiety-related conditions, and growing expenditure on preventive pet care. Value is increasingly concentrated in premium calming products featuring science-backed ingredients, veterinarian recommendations, natural formulations, and convenient delivery formats, while adoption continues to expand beyond severe anxiety management into everyday stress reduction associated with travel, separation, grooming, veterinary visits, thunderstorms, and fireworks. However, the market remains highly fragmented and competitive due to the abundance of OTC products and varying efficacy perceptions, making ingredient credibility, clinical support, product effectiveness, brand trust, and distribution reach key competitive differentiators.
Pet Type Insights
Based on pet type, pet calming supplements for dogs led the market with the largest revenue share of 52.3% in 2025. Dog calming products are becoming increasingly popular among dog owners looking for ways to reduce their pets' anxiety and stress. According to the article “Prevalence, comorbidity, and breed differences in canine anxiety in 13,700 Finnish pet dogs,” published in Scientific Reports in March 2020,” a study done on 264 dog breeds in Finland, found that more than 70% of dogs exhibited some anxiousness or stress-related behavior, with noise sensitivity being the most prevalent. Dogs, like humans, can experience stress and anxiety, which can lead to behavioral issues and health problems if left untreated. Calming products can help alleviate these symptoms and improve the dog's overall well-being.
Usage of pet calming products among cats is expected to increase at the fastest CAGR over the forecast period. Cats can experience stress and anxiety in response to various situations such as travel, grooming, and veterinary visits. Such stress can lead to behavioral problems like hiding, aggression, and inappropriate elimination. To help cats deal with these issues, cat owners are increasingly adopting cat-calming products like chews, snacks, and treats. Several brands have been operating in this segment with a focus toward innovation and novelty to offer pet owners with easy-to-use products. For instance, in June 2022, Animal Science Labs launched a new product to treat cat anxiety using the owner's natural scent. Kitty Comfort Spray combines therapeutic-grade essential oils with the cat owner's scent molecules in a highly concentrated composition. The spray would remind a cat of their owner, even if the owner is not physically present, and comfort them.
Product Insights
Based on product, snacks and treats led the market with the largest revenue share of 37.9% in 2025. Pet calming snacks and treats are natural supplements designed to help soothe and relax pets. They can be given to pets as treats or chews and are intended to be used as a supplement to other anxiety-reducing techniques, such as exercise, training, and environmental enrichment. In recent years CBD and hemp-derived dog treats are gaining traction because they offer a natural and non-toxic way to help soothe and relax pets. These treats are typically made with high-quality ingredients and are free from harmful chemicals and additives, making them a safer and more effective option for pets with sensitive stomachs or allergies. In April 2021, U.S.-based YUP PUP launched its all-natural hemp-derived CBD dog treat. The products are available in three variants and are formulated with all-natural and human-grade ingredients.
The pet calming gel and ointments industry is expected to grow at the fastest CAGR over the forecast period. Several brands have been entering this segment and releasing products. The Anxious Pet, for instance, offers Soothe Move CBD Soothing Balm. It relieves anxiety in dogs as well as cats while protecting, healing, and moisturizing areas like elbows, paw pads, and snouts. The product contains 500 mg of CBD, 100% natural ingredients and is tested by an independent third party.
Type Insights
Based on type, over-the-counter (OTC) pet calming products led the market with the largest revenue share of 62.9% in 2025. Recent investment moves, especially mergers & acquisitions, have resulted in resource availability to develop new and innovative OTC pet calming products that are safe, effective, and meet the evolving needs of pet owners. For instance, in July 2020, NXMH, a Belgian investment firm, acquired Whitebridge Pet Brands. NXMH focuses on expanding its product portfolio through acquisitions and product development. Investors are targeting market players with strong, sustainable growth and robust & improving margins and that have demonstrated performance over time. Moreover, they are also looking for companies with a strong e-commerce presence. Investments in the pet industry could lead to the expansion of distribution channels for OTC pet calming products, making them more widely available to pet owners.
The prescription pet calming products industry is projected to grow at the fastest CAGR over the forecast period. Prescription-based pet calming products are formulated with ingredients that are safe for pets with the appropriate dose for their size and weight. These are prescribed by a veterinarian who has evaluated the pet's health and determined that the benefits of the medication outweigh any potential risks. This ensures that the pet is receiving safe and appropriate treatment. Nowadays, pet owners treat their pets as family members, taking every measure to improve their quality of life. This has led to an increased demand for prescription-based pet calming products.
Ingredient Insights
Based on ingredient, pet calming products with melatonin led the market with the largest revenue share of 27.5% in 2025. These are gaining popularity due to their natural and non-addictive properties, appealing to pet owners seeking gentle solutions for stress and anxiety in pets. Melatonin helps regulate sleep and relaxation in animals, making it effective for situations like travel, storms, or separation anxiety. Its widespread use in humans for similar purposes adds to consumer trust. Additionally, these products are available in various forms, such as chews and sprays, increasing accessibility and convenience.
Pet calming products with herbal ingredients (Valerian root, chamomile, ginger root, passion flower, etc) is projected to grow at the fastest CAGR over the forecast period. Such products are gaining popularity as pet owners increasingly prefer natural, holistic solutions for anxiety and stress. Ingredients like chamomile, valerian root, and passionflower appeal to consumers seeking safe, chemical-free options. This trend aligns with growing awareness of pet wellness and the desire for eco-friendly, sustainable products.
In April 2024, Cymbiotika launched its pet line, Cymbiotika Pets, featuring high-quality supplements for dogs. The line included "Dog’s Calm," a duck-flavored soft chew formulated with natural ingredients like chamomile, valerian root, GABA, and L-theanine. Designed to alleviate stress and anxiety caused by environmental factors, it aimed to promote relaxation and overall well-being in dogs.
Distribution Channel Insights
Based on distribution channel, sales of pet calming products through the offline channel led the market with the largest revenue share of 66.2% in 2025. Amidst the continued boom in the pet industry, several market players have been expanding their reach to tap consumers in an offline setting. Bunnings, an Australian household hardware and garden center chain, released its first range of pet products in March 2023. The retailer introduced more than 700 items in its wide selection of pet care goods, and it also sells products by brands like Happy Tails, Baxter & Bone, and PetZone.
To learn more about this report, Download Free Sample Report Sales through the online sales channel is expected to expand at the fastest CAGR over the forecast period. The online and e-commerce platforms in pet calming products industry are expected to grow significantly during the forecast period, owing to the diverse product offerings, ease of shopping, and hefty discounts offered. Moreover, the pandemic paved a way for the development of online and e-commerce platforms.
Recognizing the e-commerce and digitalization revolution, key players in the market are collaborating with companies to strengthen their online presence. For instance, in April 2021, Central Garden & Pet Company collaborated with Profitero, Inc. to strengthen its online presence and accelerate e-commerce growth as pet purchases through online shopping surge. Such instances coupled with factors driving online shopping are expected to grow the pheromone-based market.
Regional Insights
North America dominated the pet calming products market with the largest revenue share of 39.1% in 2025. The market here is growing primarily due to the rise in pet adoption. According to data published by Forever Vets in February 2022, pet ownership in the U.S. is on the rise. The number of pets, including dogs and cats, rose from 140 million in 2019 to 149 million in 2020. Moreover, many of these new pet owners are more aware of their pets' emotional and behavioral needs, contributing to increased demand for calming solutions.
To learn more about this report, Download Free Sample Report U.S. Pet Calming Products Market Trends
The pet calming products market in U.S. held the largest share in the North America region in 2025. There is a growing trend of treating pets as family members and are willing to invest in products that improve their pets' well-being, including pheromone-based calming solutions. North America experiences monsoon lighting and a countless number of storms. According to the NOAA National Severe Storms Laboratory data, the U.S. alone experiences approximately 100,000 thunderstorms each year. These environmental changes cause anxiety and stress among pets, and they need calming procedures to soothe them.
Europe Pet Calming Products Market Trends
The pet calming products market in Europe accounted for a market share of 28.4% in 2025 in the global pet calming products industry. According to FEDIAF EuropeanPetFood in 2022, 90 million European families (46%) owned pets, which led to an increase in the sales of pet products and services worth over USD 20 billion. With an increasing demand for safe and effective pet calming products, regional manufacturers are developing products with natural ingredients. Zylkene, for instance, offers a capsule containing a natural ingredient called alpha-casozepine, derived from milk protein. The capsule is designed to help calm dogs and cats in stressful situations. Also, Camex offers a chewable tablet made from the natural ingredient L-tryptophan, an amino acid that helps reduce anxiety and promote relaxation in pets.
Asia Pacific Pet Calming Products Market Trends
The pet calming products market in Asia Pacific is anticipated to rise at a CAGR of about 7.7% from 2026 to 2033. As more people move to cities, pets are living in smaller spaces and being exposed to more stressors such as traffic and noise pollution. With the rise in pet ownership in this region, there is a growing demand for products that can help pets cope with anxiety and stress. This has led to collaborations among the players in the pet calming products industry. For instance, in December 2022, JD Pet Health announced its partnership with the U.S. manufacturer Zesty Paws. Through this collaboration, Zesty Paws entered the Chinese market, with JD Pet Health as its first Chinese retail partner.
Key Pet Calming Products Company Insights
The market is fragmented in nature. The industry is highly competitive, with a range of companies offering various products. Many big players are increasing their focus on new product launches, partnerships, and expansion into new markets to compete effectively.
Key Pet Calming Products Companies:
The following key companies have been profiled for this study on the pet calming products market.
-
Nestlé Purina Petcare
-
Virbac
-
NOWFoods
-
Zoetis Inc.
-
PetHonesty
-
Zesty Paws
-
THUNDERWORKS
-
PetIQ, LLC.
-
CEVA (ADAPTIL)
-
GARMON CORP. (NaturVet)
Competitive Benchmarking
Category
Operating Strategies
Competitive Edge
Weakness
Established Players (Nestlé Purina PetCare, Virbac, Zoetis Inc., CEVA (ADAPTIL), PetIQ, LLC.)
- Focus on expanding pet calming product portfolios through functional supplements, pheromone-based solutions, veterinary-backed formulations, and broad omnichannel distribution across veterinary clinics, pet specialty retailers, mass retail, and e-commerce. Invest in R&D, regulatory compliance, and strategic acquisitions to strengthen product offerings.
- Strong brand recognition, extensive global distribution networks, established relationships with veterinarians and retailers, robust research capabilities, and high consumer trust in product quality and safety.
- Higher operating and regulatory compliance costs, longer product development cycles, and comparatively slower response to rapidly changing consumer preferences and emerging wellness trends.
Emerging Players (PetHonesty, Zesty Paws, NOW Foods, THUNDERWORKS, GARMON CORP. (NaturVet))
- Focus on natural and plant-based calming supplements, functional chews, direct-to-consumer sales, digital-first marketing, subscription models, and rapid product innovation targeting pet wellness and anxiety management.
- Greater agility in responding to consumer trends, strong online presence, focus on clean-label and premium ingredients, and ability to quickly launch new formulations and niche products.
- Limited international presence, smaller distribution networks outside online channels, lower R&D and marketing budgets, and greater dependence on third-party manufacturing and digital customer acquisition.
Recent Developments
-
In November 2024, PetFriendly introduced Mellow, a line of pheromone-based pet calming products designed to reduce stress and anxiety in cats and dogs. The line included a diffuser and spray, offering solutions for common triggers like fireworks, thunderstorms, and separation anxiety. The diffuser, using Passive Evaporation Technology, provided 30 days of calming effects in spaces up to 700 square feet, while the spray offered portable relief for travel and vet visits.
-
In December 2023, PetIQ, Inc. launched the SENTRY Portable Calming Diffuser for dogs and cats, designed to ease pet stress during the holiday season and beyond. The diffuser used patented pheromone technology to lower pets’ heart rates and promote relaxation for up to 30 days without electricity. Ideal for areas pets frequent, and it helped address stress-related behaviors like barking, marking, and scratching. Pet parents could easily replace cartridges for continuous calming support.
-
For instance, in September 2022, Zesty Paws expanded its portfolio with the launch of three cat-specific products. The Hemp Elements Plus Calming Bites in the collection include broad-spectrum hemp extract, ashwagandha, melatonin, and similar ingredients to promote a feeling of calmness in cats.
Pet Calming Products Report Scope
Report Attribute
Details
Market size in 2025
USD 18.1 billion
Estimated market size in 2026
USD 19.1 billion
Projected market size by 2033
USD 29.9 billion
Growth rate
CAGR of 6.6 % from 2026 to 2033
Base year for estimation
2025
Historical data
2021 - 2024
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million/billion and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Pet type, product, type, ingredient, distribution channel
Regional scope
North America; Europe; Asia Pacific; Central & South America; Middle East & Africa
Country scope
U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; China; Japan; India; South Korea; Australia & New Zealand; Brazil; and South Africa
Key companies profiled
Nestlé Purina Petcare; Virbac; NOWFoods; Zoetis Inc.; PetHonesty; Zesty Paws; THUNDERWORKS; PetIQ, LLC.; CEVA (ADAPTIL); GARMON CORP. (NaturVet)
Customization scope
Free report customization (equivalent up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Pet Calming Products Market Report Segmentation
This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. or this study, Grand View Research has segmented the global pet calming products report on the basis of pet, product, type, ingredient, distribution channel, and region.
-
Pet Outlook (Revenue, USD Billion, 2021 - 2033)
-
Dog
-
Cat
-
Others
-
-
Product Outlook (Revenue, USD Billion, 2021 - 2033)
-
Food & Supplements
-
Snack & Treats
-
Gel & Ointment
-
Spray & Mist
-
Others
-
-
Type Outlook (Revenue, USD Billion, 2021 - 2033)
-
Prescription
-
Over-the-counter (OTC)
-
-
Ingredient Outlook (Revenue, USD Billion, 2021 - 2033)
-
Melatonin
-
L-theanine
-
Vitamin B1
-
Herbal Ingredients
-
Others
-
-
Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
-
Offline
-
Online
-
-
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
-
Asia Pacific
-
China
-
Japan
-
India
-
-
Central & South America
-
Brazil
-
-
Middle East & Africa
-
South Africa
-
-
Research Methodology
The pet calming products market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing - reconciling supply-side and demand-side estimates - and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each pet calming products segment quantified using the revenue-capture definitions in the table below.
Segment Definition
Segment - Product
Revenue capture definition
Food & Supplements
Revenue is generated through the sale of calming supplements, powders, capsules, tablets, and functional food products formulated to help manage stress, anxiety, and behavioral issues in pets. Revenue includes purchases through veterinary clinics, pet specialty stores, pharmacies, and e-commerce platforms.
Snack & Treats
Revenue is generated through the sale of calming treats and chewable products containing ingredients intended to support relaxation and stress management in pets. Revenue includes purchases by pet owners seeking convenient and palatable anxiety-relief solutions for dogs, cats, and other companion animals.
Gel & Ointment
Revenue is generated through the sale of calming gels, pastes, and topical formulations designed to support stress reduction and behavioral wellness in pets. Revenue includes sales through veterinary channels, pet care retailers, and online platforms.
Spray & Mist
Revenue is generated through the sale of calming sprays, mists, and pheromone-based products used to create a relaxing environment or reduce anxiety-related behaviors in pets. Revenue includes purchases for use during travel, grooming, veterinary visits, and other stress-inducing situations.
Others
Revenue is generated through the sale of other pet calming products, including collars, diffusers, wipes, wearable calming solutions, and specialty behavioral wellness products designed to help manage anxiety and stress in companion animals.
Estimation Model
Layer Name
Key Question
Description
Population Layer
Who forms the base consumer pool?
Total companion animals, primarily dogs and cats, living in households and care facilities where stress, anxiety, behavioral issues, travel-related discomfort, noise sensitivity, or separation anxiety may create demand for calming solutions.
Access Layer
Who has access to pet calming product ecosystems?
Pet owners with access to veterinary clinics, pet specialty retailers, supermarkets, pharmacies, e-commerce platforms, and other distribution channels offering calming treats, supplements, pheromone products, calming apparel, and related solutions.
Behavioral Layer
Who actively uses pet calming products?
Pets experiencing anxiety-related behaviors associated with separation, travel, grooming, veterinary visits, thunderstorms, fireworks, aging, or environmental changes, filtered by product awareness, veterinarian recommendations, and owner purchasing behavior.
Monetisation Layer
How much revenue is generated?
Revenue derived from active users of pet calming products multiplied by average annual spending on calming treats, supplements, pheromone diffusers, sprays, calming collars, anxiety-relief apparel, and other behavioral wellness solutions across dogs, cats, and other companion animals.
Delivered Customizations
This report has been delivered with the following In-depth customizations
Client Request
Customization Delivered
Value Adds
Ingredient Effectiveness & Adoption Analysis (Ingredient × Product Format Mapping)
Evaluated the use of melatonin, L-theanine, Vitamin B1, herbal ingredients, pheromones, probiotics, and other calming agents across treats, supplements, sprays, gels, and other product formats to identify ingredient-product fit and market adoption patterns.
Helps manufacturers prioritize ingredient investments, identify high-growth formulation trends, and optimize product development strategies.
Prescription-to-OTC Migration Assessment (Type × Consumer Purchase Behavior Analysis)
Assessed the shift from prescription-based calming solutions toward OTC products, evaluating how product accessibility, pet owner preferences, and preventive wellness trends are influencing purchasing decisions.
Identifies emerging growth opportunities within the OTC segment and supports portfolio expansion and commercialization strategies.
Pet Anxiety Management Ecosystem Analysis (Pet Type × Product Usage Mapping)
Evaluated how calming products are utilized across dogs, cats, and other companion animals for separation anxiety, travel stress, noise phobias, grooming-related stress, and behavioral management applications.
Reveals where demand is structurally concentrated and helps identify underserved pet segments and application areas.
Frequently Asked Questions About This Report
The melatonin segment led with a 27.5% revenue share in 2025, while the herbal ingredients segment is the fastest-growing.
Snacks and treats led with a 37.9% revenue share in 2025, while gel and ointments is the fastest-growing segment over the forecast period.
The sale of pet calming products through offline channels accounted for the largest revenue share (over 66.0%) in 2025, and online sales are the fastest-growing segment.
Pet calming products for dogs led the market with a revenue share of 52.3% in 2025, whereas pet calming products for cats is the fastest growing segment over the forecast period.
Key players include Nestlé Purina Petcare; Virbac; NOW Foods; Zoetis Inc.; PetHonesty; Zesty Paws; THUNDERWORKS; PetIQ, LLC.; CEVA (ADAPTIL); GARMON CORP. (NaturVet).
The global pet calming products market size was valued at USD 18.1 billion in 2025 and is estimated at USD 19.1 billion for 2026.
The global pet calming products market is expected to grow at a CAGR of 6.6% from 2026 to 2033, reaching USD 29.9 billion by 2033.
Key factors that are driving the pet calming products market growth includes the humanization of pets, impact of COVID-19 pandemic on human-pet relations, and increasing studies proving the efficacy of such products.
North America dominated with a 39.1% revenue share in 2025.
The over-the-counter (OTC) segment led with a 62.9% revenue share in 2025, while the prescription segment is the fastest-growing.
About the Author(s)
Beauty & Personal Care Research Team
Consumer Goods · Beauty & Personal CareThis report was authored by the beauty & personal care research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the beauty & personal care segment of the consumer goods industry. All findings are based on proprietary consumer goods databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
